Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The stratum corneum lipid lamellae (SCLL) constitute the extracellular lipid matrix of the skin's outermost layer, serving as the body's primary permeability barrier (Source 1.3.2, 1.3.4). Composed mainly of ceramides, cholesterol, and free fatty acids in an approximately equimolar ratio, these lipids are organized into highly ordered lamellar structures that prevent excessive transepidermal water loss (TEWL) and block the entry of environmental allergens and pathogens (Source 1.1.2, 1.3.2). In diseases like atopic dermatitis and psoriasis, the composition and structural integrity of the SCLL are compromised, leading to barrier dysfunction and chronic inflammation (Source 1.1.1, 1.3.5). Therapeutic interventions target this matrix through the topical application of physiological lipids to restore structural order or occlusive agents to provide a temporary physical shield (Source 1.1.1, 1.4.3). Additionally, certain drugs can stimulate the endogenous synthesis of these lipids by activating nuclear receptors such as PPARs and LXR, thereby reinforcing the skin's natural defense mechanisms (Source 1.4.1). Maintaining the integrity of the lipid lamellae is crucial for skin health and the prevention of chronic inflammatory skin diseases (Source 1.2.1).
Restoration of the skin's permeability barrier by replenishing essential lipids (ceramides, cholesterol, and fatty acids), providing an occlusive layer to prevent transepidermal water loss, or stimulating endogenous lipid synthesis via nuclear receptors like PPARs and LXR.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum lipid lamellae (SCLL).